Pancreatic Cancer section

Prostate Cancer News & Features

Cognitive Therapy Not More Effective Than Usual Care for Distress Reduction in Advanced PCa

Cognitive Therapy Not More Effective Than Usual Care for Distress Reduction in Advanced PCa

Advanced prostate cancer is associated with substantial psychosocial morbidity; therefore, this study was conducted to evaluate whether mindfulness-based cognitive therapy reduces distress in this population.

Guidelines Issued for Prostate MRI After Negative Biopsy

Guidelines Issued for Prostate MRI After Negative Biopsy

Consensus statement presents guidelines for prostate magnetic resonance imaging (MRI) in patients with negative biopsy.

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

[Clinical Medicine Insights: Oncology] This research examines the various mechanisms of resistance to chemotherapy in metastatic CRPC and the potential role of emerging regimens and agents in varying clinical phases of development.

Second Opinions Rarely Change Prostate Cancer Decisions

Second Opinions Rarely Change Prostate Cancer Decisions

The impact of additional opinions on patient decision-making is limited.

Study Shows Effects of 2012 USPSTF Recommendation Against PSA Screening

Study Shows Effects of 2012 USPSTF Recommendation Against PSA Screening

Researchers report on their evaluation of the impact of the 2012 USPSTF recommendation on volumes of prostate biopsy and radical prostatectomy.

Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered

Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered

Researchers analyzed data from the NPCR of Sweden to determine whether more US men with prostate cancer would choose active surveillance if it were presented as a treatment option.

Androgen Deprivation Therapy for Prostate Cancer May Increase Dementia Risk

Androgen Deprivation Therapy for Prostate Cancer May Increase Dementia Risk

Growing evidence suggests a link between androgen deprivation therapy (ADT) and cognitive dysfunction, but whether it may contribute to the risk of dementia more broadly is unclear. In this study, researchers examined the association of ADT with subsequent development of dementia in patients with prostate cancer.

Early Post-op RT Linked to Worse Functional Outcomes in Prostate Cancer

Early Post-op RT Linked to Worse Functional Outcomes in Prostate Cancer

Radiotherapy administered postoperatively within 1 year of radical prostatectomy was associated with worse functional outcomes compared with radiotherapy administered 1 year or more after surgery.

E-HF Radiation Therapy Side Effects Comparable to CF Radiation Therapy in Prostate Cancer

E-HF Radiation Therapy Side Effects Comparable to CF Radiation Therapy in Prostate Cancer

Side effects experienced with extremely hypofractionated treatment for intermediate-risk prostate cancer were comparable to those of conventional radiation therapy at 2 years after treatment.

Postdiagnosis Physical Activity Linked to Improved Physical QoL in Prostate Cancer Survivors

Postdiagnosis Physical Activity Linked to Improved Physical QoL in Prostate Cancer Survivors

Prostate cancer survivors who maintain or begin recreational physical activity following cancer diagnosis report substantially higher quality of life than those who never exercise or stopped exercising after diagnosis.

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs